<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02124681</url>
  </required_header>
  <id_info>
    <org_study_id>PRO13060248</org_study_id>
    <nct_id>NCT02124681</nct_id>
  </id_info>
  <brief_title>Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer</brief_title>
  <acronym>REHNIS</acronym>
  <official_title>Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current options to treat insulin resistance in diabetes are fairly limited. For this reason,
      novel treatments would represent a major progress. The generic drug hydroxychloroquine (HCQ)
      has poorly understood effects on blood sugar metabolism. In this study, the investigators
      will examine the mechanisms by which this drug affects glucose metabolism and which cells are
      affected. Findings emanating from this project will help establish whether HCQ may be a
      viable treatment for disorders of glucose metabolism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity in muscle and liver</measure>
    <time_frame>13±1 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>biomarkers of inflammation</measure>
    <time_frame>13±1 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo PO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine sulfate 400mg PO QD</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>Hydroxychloroquine sulfate 400mg/d PO for 13±1 weeks</description>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo PO for 13±1 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21-69 years-old;

          -  BMI 28-40;

          -  Presence of at least one of the following markers of insulin resistance: a) fasting
             hyperinsulinemia (&gt;7 uU/ml by ultrasensitive insulin assay); impaired fasting glucose
             (100-125 mg/dl); prior history of impaired glucose tolerance provided by the
             participant; history of previous gestational diabetes; history of PCOS; waist
             circumference &gt;40&quot; (men) or &gt;35&quot; (women) (cut-offs from ATP-III criteria for metabolic
             syndrome).

        Exclusion Criteria:

          -  Pregnancy, or unable/unwilling to avoid pregnancy during the study;

          -  Unstable cardiopulmonary disease, hepatitis, liver dysfunction, renal insufficiency,
             or any other medical condition affecting glucose metabolism or safety during the
             study;

          -  Diabetes;

          -  Medications that affect glucose metabolism: (e.g. systemic glucocorticoids,
             antipsychotics);

          -  History of hypersensitivity to local lidocaine, similar anesthetics, or HCQ;

          -  History of G6PDH deficiency;

          -  History of retinopathy;

          -  Weight instability (&gt;3Kg of weight change in the past three months);

          -  Bariatric surgery in the last two years, intention to lose weight or engage in
             exercise regimen during study;

          -  Alcohol intake &gt;1 drink/day (averaged);

          -  Hemoglobin &lt;10g%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederico Toledo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC Montefiore Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2014</study_first_submitted>
  <study_first_submitted_qc>April 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2014</study_first_posted>
  <last_update_submitted>June 2, 2017</last_update_submitted>
  <last_update_submitted_qc>June 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Frederico Toledo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

